• NEW
    Tech Launch Perspective
    Aug. 04, 2026

    SAP’s financial management product announcements at SAP Sapphire 2026 reinforce its vision for autonomous finance as part of its broader Autonomous Enterprise strategy through enhancements spanning agent-led finance execution, continuous and intelligent finance operations, enterprise AI…
  • See Us At
    July 21, 2026

    Join Sanket Anshuman, Practice Director at Everest Group, to explore how pharmacovigilance (PV) is evolving from a compliance-driven function to an AI-enabled, intelligence-led safety model. Discover how organizations can leverage AI, automation, and real-world data to…
  • PEAK Matrix®
    July 09, 2026

    Enterprises are rethinking recruitment strategies as hiring demand stabilizes following a prolonged market slowdown, while continuing to navigate economic uncertainty, budget pressures, and persistent skill shortages. Organizations are increasingly seeking flexible recruitment models that can scale…
  • Viewpoint
    July 07, 2026

    AI is no longer simply changing how talent decisions are made; it is reshaping how organizations define talent, structure work, and build workforce advantage. As enterprises accelerate AI adoption, the focus is expanding beyond process transformation…
  • Viewpoint
    June 29, 2026

    The post-approval phase represents one of the most complex and strategically critical stages in the life sciences product life cycle, requiring enterprises to ensure continuous safety monitoring, regulatory compliance, and real-world performance optimization. With increasing diverse…
  • Viewpoint
    June 23, 2026

    Artificial intelligence (AI) is rapidly becoming a core component of Talent Acquisition (TA) and HR strategy as organizations navigate evolving skill requirements, rising application volumes, and increasing pressure to deliver measurable business outcomes. While AI adoption…
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • Market Insights™
    Nov. 05, 2025

  • Blog
    Nov. 02, 2025

    The clinical outsourcing market is undergoing a transition with the emergence of specialist-focused Clinical Research Organizations (CROs). A specialist CRO concentrates its expertise in a defined area, such as a therapeutic focus, trial phase or technology, or geographic niche, rather than offering broad,…
  • Provider Compendium
    Oct. 24, 2025

    Everest Group’s Procure-to-Pay (P2P) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of nine P2P products and includes insights on the global P2P products market. It examines each product’s features, enhancements, and market adoption…
  • State of the Market
    Oct. 01, 2025

    The surge in case volumes, more stringent regulatory demands, and therapeutic areas’ rising complexities are significantly transforming pharmacovigilance (PV). As the industry adapts to more tailored reporting requirements and longer patient monitoring periods, enterprises are under…
  • Provider Compendium
    Sep. 30, 2025

    Everest Group’s Supply Chain Management (SCM) BPS – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 11 SCM service providers and includes insights into the global SCM service provider landscape. It offers detailed profiles of…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • PEAK Matrix®
    Sep. 12, 2025

    Enterprises are recalibrating procurement and finance operations as cost pressures, regulatory complexity, and rapid technology advancements intensify. Procure-to-Pay (P2P) products have become integral to unifying purchasing and Accounts Payable (AP) workflows, enabling organizations to automate processes,…
  • PEAK Matrix®
    Aug. 08, 2025

    Global disruptions and fast-paced innovations continue to impact and reshape enterprise supply chains. In this evolving landscape, Supply Chain Management (SCM) BPS providers are central in establishing resilience and driving transformation in enterprises. These providers streamline…
  • Webinar Deck
    July 31, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • Event
    July 29, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…

Items per page